The results from these studies show that ACE inhibitors significantly decreased the doubling of creatinine compared with placebo (OR=0.58; 95% credible interval, 0.32-0.9), and the use of beta-blockers significantly increased mortality risk (OR=7.13; 95% credible interval, 1.37-41.39).

Read more